A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its ...

Analysis of Clinical Characteristics and Treatment Trends in Hospitalized Patients with Cardiovascular Diseases in the Baise ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

One key aspect of talk therapy is derived from the interaction between two living, feeling and responsive human beings.

H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of MRD ...

Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular therapeutics and ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease ...